BVF PARTNERS L P/IL Insider Trading $ARQL ARQULE INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for BVF PARTNERS L P/IL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of BVF PARTNERS L P/IL. BVF PARTNERS L P/IL is 10% Owner in LIGAND PHARMACEUTICALS INC ($LGND) and 10% Owner in AVIGEN INC \DE ($AVGN) and 10% Owner in NEUROCRINE BIOSCIENCES INC ($NBIX) and 10% Owner in ARQULE INC ($ARQL) and 10% Owner in CURIS INC ($CRIS) and 10% Owner in DYNAVAX TECHNOLOGIES CORP ($DVAX) and 10% Owner in EPIRUS Biopharmaceuticals, Inc. ($CRXX).
BVF PARTNERS L P/IL in ARQULE INC
Trading Symbol: ARQLIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BVF PARTNERS L P/IL: 10% Owner
Holdings: 12,244,073 shares
Current Value: $16,774,380
Latest Transaction: Nov 25 2008
$ARQL Market Capitalization: $96.01M
$ARQL Previous Close: $1.37
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of BVF PARTNERS L P/IL in ARQULE INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ARQL, AVGN, CRIS, DVAX, CRXX, LGND, NBIX
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 25 2008 | ARQL | ARQULE INC | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.40 | 203,000 | 486,226 | 12,244,073 | 12 M to 12.2 M (+1.69 %) |
Nov 25 2008 | ARQL | ARQULE INC | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.40 | 56,000 | 134,131 | 12,041,073 | 12 M to 12 M (+0.47 %) |
Nov 25 2008 | ARQL | ARQULE INC | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.40 | 81,900 | 196,167 | 11,985,073 | 11.9 M to 12 M (+0.69 %) |
Nov 21 2008 | ARQL | ARQULE INC | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.65 | 176,000 | 466,400 | 11,903,173 | 11.7 M to 11.9 M (+1.50 %) |
Nov 21 2008 | ARQL | ARQULE INC | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.65 | 49,000 | 129,850 | 11,727,173 | 11.7 M to 11.7 M (+0.42 %) |
Nov 21 2008 | ARQL | ARQULE INC | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.65 | 69,413 | 183,944 | 11,678,173 | 11.6 M to 11.7 M (+0.60 %) |
Nov 13 2008 | ARQL | ARQULE INC | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.45 | 226,000 | 553,700 | 11,608,760 | 11.4 M to 11.6 M (+1.99 %) |
Nov 13 2008 | ARQL | ARQULE INC | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.45 | 62,000 | 151,900 | 11,382,760 | 11.3 M to 11.4 M (+0.55 %) |
Nov 13 2008 | ARQL | ARQULE INC | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.45 | 89,000 | 218,050 | 11,320,760 | 11.2 M to 11.3 M (+0.79 %) |
Nov 13 2008 | ARQL | ARQULE INC | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.25 | 247,000 | 555,750 | 11,231,760 | 11 M to 11.2 M (+2.25 %) |
Nov 13 2008 | ARQL | ARQULE INC | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.25 | 68,000 | 153,000 | 10,984,760 | 10.9 M to 11 M (+0.62 %) |
Nov 13 2008 | ARQL | ARQULE INC | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.25 | 97,200 | 218,700 | 10,916,760 | 10.8 M to 10.9 M (+0.90 %) |
Nov 13 2008 | ARQL | ARQULE INC | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.35 | 801,000 | 1,882,350 | 10,819,560 | 10 M to 10.8 M (+8.00 %) |
Nov 13 2008 | ARQL | ARQULE INC | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.35 | 220,000 | 517,000 | 10,018,560 | 9.8 M to 10 M (+2.25 %) |
Nov 13 2008 | ARQL | ARQULE INC | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.35 | 317,500 | 746,125 | 9,798,560 | 9.5 M to 9.8 M (+3.35 %) |
Page: 1